Evy Akerlund-Lundgren

Medicon Village
Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Safety and Efficacy of Allogeneic Integrin α10β1-Selected Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis: A First-In-Human Phase I/IIa Dose Escalation Study.

Safety and Efficacy of Allogeneic Integrin α10β1-Selected Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis: A First-In-Human Phase I/IIa Dose Escalation Study.

Journal: Cartilage

Published: August 03, 2026

Intraarticular treatment with integrin α10β1-selected mesenchymal stem cells affects microRNA expression in experimental post-traumatic osteoarthritis in horses.

Intraarticular treatment with integrin α10β1-selected mesenchymal stem cells affects microRNA expression in experimental post-traumatic osteoarthritis in horses.

Journal: Frontiers in veterinary science

Published: January 22, 2024

Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model.

Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model.

Journal: Cartilage

Published: November 22, 2023

Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome.

Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome.

Journal: Respiratory research

Published: March 27, 2023

Ablation of integrin-mediated cell-collagen communication alleviates fibrosis.

Ablation of integrin-mediated cell-collagen communication alleviates fibrosis.

Journal: Annals of the rheumatic diseases

Published: March 08, 2023

Temporal extracellular vesicle protein changes following intraarticular treatment with integrin α10β1-selected mesenchymal stem cells in equine osteoarthritis.

Temporal extracellular vesicle protein changes following intraarticular treatment with integrin α10β1-selected mesenchymal stem cells in equine osteoarthritis.

Journal: Frontiers in veterinary science

Published: September 29, 2022

Human integrin α10β1-selected mesenchymal stem cells home to cartilage defects in the rabbit knee and assume a chondrocyte-like phenotype.

Human integrin α10β1-selected mesenchymal stem cells home to cartilage defects in the rabbit knee and assume a chondrocyte-like phenotype.

Journal: Stem cell research & therapy

Published: March 10, 2022

Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration.

Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration.

Journal: Cancers

Published: January 19, 2021

Integrin α10β1-Selected Mesenchymal Stem Cells Mitigate the Progression of Osteoarthritis in an Equine Talar Impact Model.

Integrin α10β1-Selected Mesenchymal Stem Cells Mitigate the Progression of Osteoarthritis in an Equine Talar Impact Model.

Journal: The American journal of sports medicine

Published: February 01, 2020

Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival.

Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival.

Journal: Cancers

Published: March 22, 2019

Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes.

Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes.

Journal: Molecular therapy. Methods & clinical development

Published: September 19, 2015

Integrin α10β1: a collagen receptor critical in skeletal development.

Integrin α10β1: a collagen receptor critical in skeletal development.

Journal: Advances in experimental medicine and biology

Published: July 16, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026